Paper9028962
Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells.
Yamada T and 5 others. Blood, 1997. Cited by 83 papers, by iCite.
Cite this record
ConductScience Library. Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells. Papers, record 9028962. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9028962
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Leukemia, Erythroblastic, Acute | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Trans-Activators | Major topic |
| Animals | |
| Cell Differentiation | |
| Cell Division | |
| Dimethyl Sulfoxide | |
| Friend murine leukemia virus | |
| Gene Expression Regulation, Leukemic | |
| Mice | |
| Mutagenesis, Site-Directed | |
| Protein Structure, Tertiary | |
| Recombinant Fusion Proteins | |
| Sequence Deletion | |
| Transcription, Genetic | |
| Transfection | |
| Tumor Cells, Cultured | |
| Proto-Oncogene Protein Spi-1 |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41136556 | Super-enhancer-associated long noncoding RNA lnc-SPI1U mediates SPI1 feedback regulation by interacting with HNRNPH1 and HNRNPF. | Oncogene | 2025 | https://conductscience.org/library/papers/41136556 | PubMed |
| 33669537 | Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33669537 | PubMed |
| 30669675 | Murine Models of Acute Myeloid Leukaemia. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30669675 | PubMed |
| 28965757 | Erythroleukemia-historical perspectives and recent advances in diagnosis and management. | Blood Rev | 2018 | https://conductscience.org/library/papers/28965757 | PubMed |
| 28572446 | Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly. | FASEB J | 2017 | https://conductscience.org/library/papers/28572446 | PubMed |
| 28108556 | Confirmation of five novel susceptibility loci for systemic lupus erythematosus (SLE) and integrated network analysis of 82 SLE susceptibility loci. | Hum Mol Genet | 2017 | https://conductscience.org/library/papers/28108556 | PubMed |
| 24944809 | The differentiation effect of low-dose cytosine arabinoside is disturbed in PU.1-knockdown K562 cells. | Biomed Rep | 2014 | https://conductscience.org/library/papers/24944809 | PubMed |
| 24010046 | DNA methylation-mediated silencing of PU.1 in leukemia cells resistant to cell differentiation. | Springerplus | 2013 | https://conductscience.org/library/papers/24010046 | PubMed |
| 21845190 | PU.1 and Haematopoietic Cell Fate: Dosage Matters. | Int J Cell Biol | 2011 | https://conductscience.org/library/papers/21845190 | PubMed |
| 20190819 | Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/PU.1 oncogene autoregulation loop. | Oncogene | 2010 | https://conductscience.org/library/papers/20190819 | PubMed |
| 19491391 | Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate. | Blood | 2009 | https://conductscience.org/library/papers/19491391 | PubMed |
| 19289502 | Spi-1 and Fli-1 directly activate common target genes involved in ribosome biogenesis in Friend erythroleukemic cells. | Mol Cell Biol | 2009 | https://conductscience.org/library/papers/19289502 | PubMed |
| 17702896 | Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis. | Blood | 2007 | https://conductscience.org/library/papers/17702896 | PubMed |
| 16331260 | Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. | Oncogene | 2006 | https://conductscience.org/library/papers/16331260 | PubMed |
| 15298723 | ETS transcription factors: possible targets for cancer therapy. | Cancer Sci | 2004 | https://conductscience.org/library/papers/15298723 | PubMed |
| 14647463 | Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. | Oncogene | 2003 | https://conductscience.org/library/papers/14647463 | PubMed |
| 14647452 | Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells. | Oncogene | 2004 | https://conductscience.org/library/papers/14647452 | PubMed |
| 14559995 | PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation. | Mol Cell Biol | 2003 | https://conductscience.org/library/papers/14559995 | PubMed |
| 12556498 | Functional cross-antagonism between transcription factors FLI-1 and EKLF. | Mol Cell Biol | 2003 | https://conductscience.org/library/papers/12556498 | PubMed |
| 12439744 | Role of Ets-1 in transcriptional regulation of transferrin receptor and erythroid differentiation. | Oncogene | 2002 | https://conductscience.org/library/papers/12439744 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9028962
GET https://conductscience.org/api/papers/v1/9028962/cited_by?page=2